Supplementary Figure 5 from Combining Onartuzumab with Erlotinib Inhibits Growth of Non–Small Cell Lung Cancer with Activating <i>EGFR</i> Mutations and HGF Overexpression

crossref（2023）

引用 0|浏览5

暂无评分

摘要

Supplementary Figure 5. Recovery of MET protein levels by inhibition of MET/HGF signaling.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Supplementary Figure 5 from Combining Onartuzumab with Erlotinib Inhibits Growth of Non–Small Cell Lung Cancer with Activating &lt;i&gt;EGFR&lt;/i&gt; Mutations and HGF Overexpression